Talk to us

Knowledge center


Here you’ll find scientific research in which our platform has played a vital role, as well as downloads like infor...

News & activities

Keep up to date with what’s happening at Immuneed. We arrange seminars and events, participate in conferences and m...

White Paper

Could clinical manifestations be predicted more easily? Why you should rethink the credibility of st...

To white paper


Written by Erika Fletcher, PhD

On October 17, 2019

When is complement activation a risk?

Preclinical testing is vital to ensure the safety of clinical trials, so why is a key aspect of the body’s immune system almost systematically overlooked in preclinical assays? Complement activation is a risk – even if the classical pathway is blocked...